Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease
Annals of Neurology · 2025-04 · 97 (4) · 730-740
DOI: 10.1002/ana.27158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 24.12.2024. Verfasst von Ethan G Brown und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Synucleinopathies, Olfaction Disorders. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Objective
Remote identification of individuals with severe hyposmia may enable scalable recruitment of participants with underlying alpha‐synuclein aggregation. We evaluated the performance of a staged screening paradigm using remote smell testing to enrich for abnormal dopamine transporter single‐photon emission computed tomography imaging (DAT‐SPECT) and alpha‐synuclein aggregation.
Methods
The Parkinson's Progression Markers Initiative (PPMI) recruited participants for the prodromal cohort who were 60‐years and older without a Parkinson's disease diagnosis. Participants were invited to complete a University of Pennsylvania Smell Identification Test (UPSIT) independently through an online portal. Hyposmic participants were invited to complete DAT‐SPECT, which determined eligibility for enrollment in longitudinal assessments and further biomarker evaluation including cerebrospinal fluid alpha‐synuclein seed amplification assay (aSynSAA).
Results
As of January 29, 2024, 49,843 participants were sent an UPSIT and 31,293 (63%) completed it. Of UPSIT completers, 8,301 (27%) scored
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
- Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
- Institute for Neurodegenerative Disorders, New Haven, CT, USA.
- The Michael J. Fox Foundation, New York, NY, USA.
ORCID-Profile: Ethan G Brown, Luis Concha-Marambio, Claudio Soto
Förderung
- NIA NIH HHS
- Michael J. Fox Foundation for Parkinson's Research
Zitieren
APA
Brown, E. G., Chahine, L. M., Siderowf, A., Gochanour, C., Kurth, R., Marshall, M. J., Caspell-Garcia, C., Brumm, M. C., Stanley, C. E., Korell, M., McMahon, B., Kuhl, M., Fabrizio, K., Heathers, L., Concha-Marambio, L., Soto, C., Chowdhury, S., Coffey, C. S., Foroud, T. M., …, & Parkinson Progression Marker Initiative (2025). Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease. Annals of Neurology, 97(4), 730-740. https://doi.org/10.1002/ana.27158
Vancouver
Brown EG, Chahine LM, Siderowf A, Gochanour C, Kurth R, Marshall MJ, et al. Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease. Annals of Neurology. 2025;97(4):730-740. doi:10.1002/ana.27158
BibTeX
@article{Brown2025,
author = {Brown, Ethan G and Chahine, Lana M and Siderowf, Andrew and Gochanour, Caroline and Kurth, Ryan and Marshall, Micah J and Caspell-Garcia, Chelsea and Brumm, Michael C and Stanley, Craig E and Korell, Monica and McMahon, Bridget and Kuhl, Maggie and Fabrizio, Kimberly and Heathers, Laura and Concha-Marambio, Luis and Soto, Claudio and Chowdhury, Sohini and Coffey, Christopher S and Foroud, Tatiana M and Simuni, Tanya and Marek, Kenneth and Tanner, Caroline M and Parkinson Progression Marker Initiative, Parkinson Progression Marker Initiative},
title = {Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease},
journal = {Annals of Neurology},
year = {2025},
volume = {97},
number = {4},
pages = {730--740},
doi = {10.1002/ana.27158}
}
EUVIMED